Kratom isn’t included in America federal listing of managed substances, although the DEA considers it a “drug of worry.A scientific critique of (pre)medical scientific studies within the therapeutic possible and safety profile of kratom in people. Hum Psychopharmacol. 2022;37(1):e2805. . Experts worry there’s very little scientific proof supp